<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00286741</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 03-084</org_study_id>
    <nct_id>NCT00286741</nct_id>
  </id_info>
  <brief_title>Can Group Visits Improve Outcomes of Veterans With Diabetes</brief_title>
  <official_title>Can Group Visits Improve Outcomes of Veterans With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Diabetes is a common, morbid and expensive disease among veterans. Achieving
      adequate glycemic control and blood pressure control can reduce the devastating complications
      of diabetes. Because the majority of patients do not achieve adequate control of blood sugar
      and blood pressure, innovative strategies to improve control are needed. One strategy with
      great potential for veterans receiving VA care is the group clinic. Group clinics have been
      developed over the last 5-10 years, and have been shown to improve clinical outcomes and
      reduce outpatient utilization in geriatric settings. Group medical clinics involve a cohort
      of 8-20 patients who have 1-2 hour group visits. These clinics are distinguished from
      traditional group education visits for diabetes by the fact that these visits involve one
      physician and one or more additional health care professionals, usually a nurse practitioner
      and/or a pharmacist, and are designed to make management changes for a number of people with
      the same disease in a short period of time. The effect of group medical clinics on blood
      sugar, blood pressure, and the cost of diabetes care, is unknown. Objectives: Our primary
      objectives in this project are to determine the effectiveness and cost-effectiveness of a
      group visit intervention in improving rates of control of diabetes and high blood pressure in
      patients with both illnesses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Diabetes is a common, morbid and expensive disease among veterans. Achieving adequate
      glycemic control and blood pressure control can reduce the devastating complications of
      diabetes. Because the majority of patients do not achieve adequate control of blood sugar and
      blood pressure, innovative strategies to improve control are needed. One strategy with great
      potential for veterans receiving VA care is the group clinic. Group clinics have been
      developed over the last 5-10 years, and have been shown to improve clinical outcomes and
      reduce outpatient utilization in geriatric settings. Group medical clinics involve a cohort
      of 8-20 patients who have 1-2 hour group visits. These clinics are distinguished from
      traditional group education visits for diabetes by the fact that these visits involve one
      physician and one or more additional health care professionals, usually a nurse practitioner
      and/or a pharmacist, and are designed to make management changes for a number of people with
      the same disease in a short period of time. The effect of group medical clinics on blood
      sugar, blood pressure, and the cost of diabetes care, is unknown.

      Objectives:

      Our primary objectives in this project were to determine the effectiveness and
      cost-effectiveness of a group visit intervention in improving rates of control of diabetes
      and high blood pressure in patients with both illnesses.

      Methods:

      We performed a two-site, randomized, controlled trial of group medical visits for diabetes
      management. Patients were patients in primary care at the Durham or Richmond VAMC's who had
      inadequate control of both their blood sugar and their blood pressure. We excluded patients
      with life-limiting illness. Patients randomized to the control arm received usual primary
      care. Patients randomized to the intervention arm were assigned to attend a group medical
      clinic every two months for one year. In the clinic, a primary care physician, with the
      assistance of a nurse and a pharmacist, measured blood pressure at the point of care,
      reviewed blood sugar logs, and then made all necessary medical changes for patients with
      diabetes. The primary outcomes were hemoglobin A1c and systolic blood pressure. Additional
      outcomes will be serum LDL-cholesterol, diabetes-specific quality of life, and health
      services utilization. Formative evaluation was undertaken to determine the mechanism of the
      intervention and to prepare for more successful dissemination if the intervention is
      effective. Formal cost analysis will be performed and cost-effectiveness analysis will be
      undertaken. All outcomes were measured at baseline, and 6 and 12 months after the beginning
      of the intervention.

      Status:

      All patient contact complete. Project is in analysis phase.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness, Proportion of Patients With LDL &lt; 100, Health Services Utilization, Quality of Life (as Measured by DQoL), Patient Empowerment (as Measured by DES).</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">239</enrollment>
  <condition>Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Medical group visits</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medical group visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as Usual control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diabetes Group Management Visits</intervention_name>
    <description>Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
    <arm_group_label>Medical group visits</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary care at one of two participating sites,

          -  HbA1c &gt;= 7.5%, Systolic BP &gt; 140 OR Diastolic BP &gt; 90 on 2 consecutive measurements

        Exclusion Criteria:

        -Primary care provider excludes patient from study, -Patient states that primary care is
        shared with non-VA primary care provider, -New enrollment in endocrine clinic within the
        last 6 months, -Patient is reluctant to participate in group visit for any reason, -Reduced
        life expectancy, as determined by any of the following: -New York Heart Association Class
        IV congestive heart failure, -Lung disease requiring supplemental oxygen, -End-stage renal
        disease on dialysis, -Current malignancy with any evidence of disease or currently
        undergoing chemotherapy or radiation therapy, -Cirrhosis of the liver, or -AIDS (HIV
        disease does not exclude a patient in the absence of an AIDS diagnosis), -Five or more
        errors on Short Portable Mental Status Questionnaire, Psychotic illness with
        hospitalization within three years prior to enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Edelman, MD MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center, Durham, NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Durham VA Medical Center, Durham, NC</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center, Richmond, VA</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Edelman D, Fredrickson SK, Melnyk SD, Coffman CJ, Jeffreys AS, Datta S, Jackson GL, Harris AC, Hamilton NS, Stewart H, Stein J, Weinberger M. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med. 2010 Jun 1;152(11):689-96. doi: 10.7326/0003-4819-152-11-201006010-00001.</citation>
    <PMID>20513826</PMID>
  </results_reference>
  <results_reference>
    <citation>Crowley MJ, Melnyk SD, Ostroff JL, Fredrickson SK, Jeffreys AS, Coffman CJ, Edelman D. Can group medical clinics improve lipid management in diabetes? Am J Med. 2014 Feb;127(2):145-51. doi: 10.1016/j.amjmed.2013.09.027. Epub 2013 Oct 15.</citation>
    <PMID>24462012</PMID>
  </results_reference>
  <results_reference>
    <citation>Jackson GL, Edelman D, Olsen MK, Smith VA, Maciejewski ML. Benefits of participation in diabetes group visits after trial completion. JAMA Intern Med. 2013 Apr 8;173(7):590-2. doi: 10.1001/jamainternmed.2013.2803.</citation>
    <PMID>23478796</PMID>
  </results_reference>
  <results_reference>
    <citation>Crowley MJ, Melnyk SD, Coffman CJ, Jeffreys AS, Edelman D. Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention. Diabetes Care. 2013 Jul;36(7):1954-60. doi: 10.2337/dc12-1905. Epub 2013 Feb 7.</citation>
    <PMID>23393214</PMID>
  </results_reference>
  <results_reference>
    <citation>Edelman D, Dolor RJ, Coffman CJ, Pereira KC, Granger BB, Lindquist JH, Neary AM, Harris AJ, Bosworth HB. Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial. J Gen Intern Med. 2015 May;30(5):626-33. doi: 10.1007/s11606-014-3154-9. Epub 2015 Jan 8.</citation>
    <PMID>25567758</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2006</study_first_submitted>
  <study_first_submitted_qc>February 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2006</study_first_posted>
  <results_first_submitted>July 31, 2014</results_first_submitted>
  <results_first_submitted_qc>September 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Randomized controlled trials</keyword>
  <keyword>cost-effectiveness</keyword>
  <keyword>health services</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Medical Group Visits</title>
          <description>Medical group visits
Diabetes Group Management Visits: Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="133"/>
                <participants group_id="P2" count="106"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Medical group visits
Diabetes Group Management Visits: Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="133"/>
            <count group_id="B2" value="106"/>
            <count group_id="B3" value="239"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" spread="9.4"/>
                    <measurement group_id="B2" value="60.8" spread="10"/>
                    <measurement group_id="B3" value="62.0" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="127"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="128"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hemoglobin A1c</title>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medical Group Visits</title>
            <description>Diabetes Group Management Visits: Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Treatment as Usual Control</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin A1c</title>
          <units>percentage points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="1.3"/>
                    <measurement group_id="O2" value="8.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.15</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost-effectiveness, Proportion of Patients With LDL &lt; 100, Health Services Utilization, Quality of Life (as Measured by DQoL), Patient Empowerment (as Measured by DES).</title>
        <time_frame>one year</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Systolic Blood Pressure</title>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medical Group Visits</title>
            <description>Medical group visits
Diabetes Group Management Visits: Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
          </group>
          <group group_id="O2">
            <title>Treatment as Usual Control</title>
            <description>control</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140" spread="14.8"/>
                    <measurement group_id="O2" value="147" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Medical Group Visits</title>
          <description>Diabetes Group Management Visits: Patients meet in groups and receive education about diabetes, reinforcing each other with their own experiences. Each patient also gets medication management by a physician and pharmacist.</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Treatment as Usual Control</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>All-Cause hospitalization</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="122" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="85" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <description>Patient self-report, or blood glucose measured &lt; 60</description>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic insufficiency</sub_title>
                <description>Aspartate aminotransferase or alanine aminotransferase &gt; 50 U/liter</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal insufficiency</sub_title>
                <description>Decrease in estimate Glomerular Filtration Rate &gt; 10 ml/min/1.73 m2</description>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Systolic Blood Pressure &lt; 100</description>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lightheadedness</sub_title>
                <description>Patient self-report</description>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Edelman</name_or_title>
      <organization>Durham VA Medical Center</organization>
      <phone>919-286-6936</phone>
      <email>dedelman@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

